PDF(2268 KB)
Improvement effect of rubusoside on motor dysfunction and neuroinflammation in mice with spinal cord injury and its mechanism
Shuang YANG,Na XU,Jianxu ZHANG,Chengbiao SUN,Yan WANG,Mingxin DONG,Wensen LIU
PDF(2268 KB)
PDF(2268 KB)
Improvement effect of rubusoside on motor dysfunction and neuroinflammation in mice with spinal cord injury and its mechanism
Objective To discuss the effect of rubusoside (RUB) on the spinal cord injury (SCI) and neuroinflammation in the mice, and to clarify its mechanism. Methods A total of 48 female Kunming mice were randomly divided into sham operation group, SCI group, SCI+low dose of RUB group, and SCI+high dose of RUB group, and there were 12 mice in each group. Spinal cord injury behavior (BBB) scoring method was used to assess the motor function of the hind limbs of the SCI mice; water content method was used to detect the spinal cord edema of the SCI mice; real-time fluorscence quantitative PCR (RT-qPCR) method was used to detect the expression levels of pro-inflammatory cytokines cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) mRNA of the mice in various groups; ELISA method was used to detect the levels of inflammatory factors in serum of the mice in various groups; HE staining was used to observe the pathomorphology of spinal cord tissue of the mice in various groups;immunofluorescence was used to detect the activation of microglia in spinal cord tissue of the mice in various groups; Western blotting method was used to detect the expression levels of related proteins in spinal cord tissue of the mice in various groups. Results The BBB score analysis results showed that compared with sham operation group, the score of the mice in SCI group was decreased to 0; compared with SCI group, the BBB scores of the mice in SCI+low dose of RUB group and SCI+high dose of RUB group were gradually increased. The spinal cord tissue water content detection results showed that compared with sham operation group, the water content in spinal cord tissue of the mice in SCI group was significantly increased (P<0.01); compared with SCI group, the water contents in spinal cord tissue of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group were significantly decreased (P<0.01). The RT-qPCR results showed that compared with sham operation group, the expression levels of COX-2, IL-1β, and TNF-α mRNA in spinal cord tissue of the mice in SCI group were significantly increased (P<0.001). Compared with SCI group, the expression levels of COX-2,IL-1,and TNF-α mRNA in spinal cord tissue of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group were significantly decreased (P<0.001). The ELISA results showed that compared with sham operation group,the levels of IL-1β (P<0.01) and TNF-α (P<0.001) in serum of the mice in SCI group were increased; compared with SCI group, the levels of IL-1β and TNF-α in spinal cord tissue of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group were decreased (P<0.001).The Western blotting results showed that compared with sham operation group, the expression levels of nuclear factor kappa B (NF-κB) inhibitor protein-α (IκB-α), phosphorylated IκB-α (p-IκB-α), phosphorylated p65 (p-p65), p65, phosphorylated p38 (p-p38), phosphorylated extracellular regulated protein kinase (p-ERK), and phosphorylated c-Jun N-terminal kinase (p-JNK) proteins in spinal cord tissue of the mice in SCI group were significantly increased (P<0.05 or P<0.001); compared with SCI group, the expression levels of IκB-α, p-IκB-α, p-p65, p65, p-p38, p-ERK, and p-JNK proteins in spinal cord tissue of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group were significantly decreased (P<0.001). The HE staining results showed that compared with sham operation group, the spinal cord tissue of the mice in SCI group had loose organization with the formation of vacuoles, and a large necrotic cavity was present in the center of the spinal cord; compared with SCI group, the central necrotic cavity area of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group was significantly decreased (P<0.05).The immunofluorescence results showed that compared with sham operation group, the number of positive microglia cells in spinal cord tissue of the mice in SCI group was significantly increased (P<0.001); compared with SCI group, the numbers of positive microglia cells in spinal cord tissue of the mice in SCI+ low dose of RUB group and SCI+ high dose of RUB group were significantly decreased (P<0.001). Conclusion Rubusoside can improve the motor function impairment in the SCI mice,mitigate the neuroinflammation in spinal cord tissue,and inhibit the activation of microglia. The mechanism may be related to the downregulation of expression of proteins associated with the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways in spinal cord tissue.
Rubusoside / Spinal cord injury / Neuroinflammation / Nuclear factor kappa-B / Mitogen-activated protein kinase
R363.1
| 1 | XIA M J, ZHANG Y N, WU H H, et al. Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury[J]. Int Immunopharmacol, 2022, 111: 109120. |
| 2 | XU S, WANG J, ZHONG J J, et al. CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling[J]. Clin Transl Med, 2021, 11(1): e269. |
| 3 | MI J Y, YANG Y, YAO H, et al. Inhibition of heat shock protein family A member 8 attenuates spinal cord ischemia-reperfusion injury via astrocyte NF-κB/NLRP3 inflammasome pathway: HSPA8 inhibition protects spinal ischemia-reperfusion injury[J]. J Neuroinflammation, 2021, 18(1): 170. |
| 4 | CHEN K Y, LU C S, PANG C Y, et al. Equilibrative nucleoside transporter 1 is a target to modulate neuroinflammation and improve functional recovery in mice with spinal cord injury[J]. Mol Neurobiol, 2023, 60(1): 369-381. |
| 5 | CHEN K Z, LIU S X, LI Y W, et al. Vimentin as a potential target for diverse nervous system diseases[J]. Neural Regen Res, 2023, 18(5): 969-975. |
| 6 | 邵明昊, 靳明明, 周 萍,等. CD73通过AMPK/mTOR信号通路调控脊髓损伤机制研究[J].中国免疫学杂志, 2020, 36(19): 2357-2360. |
| 7 | DUTTA D, KHAN N, WU J F, et al. Extracellular vesicles as an emerging frontier in spinal cord injury pathobiology and therapy[J]. Trends Neurosci, 2021, 44(6): 492-506. |
| 8 | MAO Y P, CHEN Z, REN Y H, et al. Whole-cell biocatalyst for rubusoside production in Saccharomyces cerevisiae[J]. J Agric Food Chem, 2021, 69(44): 13155-13163. |
| 9 | ZHANG F, KOH G Y, HOLLINGSWORTH J, et al. Reformulation of etoposide with solubility-enhancing rubusoside[J]. Int J Pharm, 2012, 434(1/2): 453-459. |
| 10 | CHEN J Z, KHISTE S K, FU X M, et al. Rubusoside-assisted solubilization of poorly soluble C(6)-Ceramide for a pilot pharmacokinetic study [J]. Prostaglandins Other Lipid Mediat, 2020, 146: 106402. |
| 11 | ZIPSER C M, CRAGG J J, GUEST J D, et al. Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials [J]. Lancet Neurol, 2022, 21(7): 659-670. |
| 12 | ZHANG H, QI R L, ZENG Y H, et al. Chinese sweet leaf tea (Rubus suavissimus) mitigates LPS-induced low-grade chronic inflammation and reduces the risk of metabolic disorders in a C57BL/6J mouse model[J]. J Agric Food Chem, 2020, 68(1): 138-146. |
| 13 | HU X, ZHANG Y F, WANG L, et al. Microglial activation in the motor cortex mediated NLRP3-related neuroinflammation and neuronal damage following spinal cord injury [J]. Front Cell Neurosci, 2022, 16: 956079. |
| 14 | JIANG F, XIA M J, ZHANG Y N, et al. Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury [J]. Front Immunol, 2022, 13: 993168. |
| 15 | CHANG J, QIAN Z Y, WANG B Y, et al. Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury [J]. Cell Commun Signal, 2023, 21(1): 37. |
| 16 | ZHAO X N, LI X X, GUO H L, et al. Resolvin D1 attenuates mechanical allodynia after burn injury: involvement of spinal glia, p38 mitogen-activated protein kinase, and brain-derived neurotrophic factor/tropomyosin-related kinase B signaling[J]. Mol Pain, 2023, 19: 17448069231159970. |
| 17 | 刘 冬, 朱志杰, 张 昭, 等. 脊髓损伤中坏死性凋亡关键基因的筛选与验证[J]. 解放军医学杂志: 1-14[2023-11-01]. . |
| 18 | SUN Q Y, HU T T, ZHANG Y R, et al. IRG1/itaconate increases IL-10 release to alleviate mechanical and thermal hypersensitivity in mice after nerve injury [J]. Front Immunol, 2022, 13: 1012442. |
| 19 | LIAO C L, ZHOU H, CHEN H J, et al. DUSP8/TAK1 signaling mediates neuropathic pain through regulating neuroinflammation and neuron death in a spinal nerve ligation (SNL) rat model [J]. Int Immunopharmacol, 2022, 113(Pt A): 109284. |
| 20 | HONG X, XIA M J, ZHANG Q Y, et al. Deficiency of CD93 exacerbates inflammation-induced activation and migration of BV2 microglia by regulating the TAK1/NF-κB pathway[J]. Neurosci Lett, 2022, 791: 136914. |
| 21 | YIN X Y, WANG C C, DU P, et al. Muse cells decrease the neuroinflammatory response by modulating the proportion of M1 and M2 microglia in vitro [J]. Neural Regen Res, 2023, 18(1): 213-218. |
| 22 | ZHANG X Q, ZHANG Q, HUANG L L, et al. Pien-Tze-Huang attenuates neuroinflammation in cerebral ischaemia-reperfusion injury in rats through the TLR4/NF-κB/MAPK pathway[J]. Pharm Biol, 2021, 59(1): 828-839. |
| 23 | WANG J, RAN Q, ZENG H R, et al. Cellular stress response mechanisms of Rhizoma coptidis: a systematic review [J]. Chin Med, 2018, 13: 27. |
| 24 | YUAN B C, YANG R, MA Y S, et al. A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications [J]. Pharm Biol, 2017, 55(1): 620-635. |
| 25 | KIM J K, YANG H J, GO Y. Quercus acuta thunb suppresses LPS-induced neuroinflammation in BV2 microglial cells via regulating MAPK/NF-κB and Nrf2/HO-1 pathway[J]. Antioxidants, 2022, 11(10): 1851. |
| 26 | KIM O H, JEON K O, JANG E Y. Alpha-pyrrolidinopentiothiophenone(α-PVT) activates the TLR- NF-κB-MAPK signaling pathway and proinflammatory cytokine production and induces behavioral sensitization in mice[J]. Pharmacol Biochem Behav, 2022, 221: 173484. |
| 27 | GUO L, LI Y Y, LI W N, et al. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson’s disease[J]. Clin Exp Pharmacol Physiol, 2022, 49(11): 1221-1231. |
/
| 〈 |
|
〉 |